share_log
Reuters ·  Mar 17 12:00
OPKO Health and Entera Bio Enter Into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate Into the Clinic to Treat Obesity and Metabolic Disorders
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 259

Recommended

Write a comment